144 related articles for article (PubMed ID: 37607775)
1. Long-term efficacy and safety of microwave ablation for hepatocellular carcinoma adjacent to the gallbladder with a diameter ≤ 5 cm: a multicenter, propensity score matching study.
Li L; Yao J; Yan X; Qi X; Liang P; Han Z; Liu F; Cheng Z; Luo Y; Zheng R; Cheng W; Wei Q; Yu S; Yu J; Yu X
Int J Hyperthermia; 2023; 40(1):2248425. PubMed ID: 37607775
[TBL] [Abstract][Full Text] [Related]
2. Microwave ablation for peribiliary hepatocellular carcinoma: propensity score analyses of long-term outcomes.
Hu H; Chi JC; Liu R; Zhai B
Int J Hyperthermia; 2021; 38(1):191-201. PubMed ID: 33682598
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy of microwave ablation in the treatment of subcapsular hepatocellular carcinomas of ≤3 cm in diameter: a multicenter, propensity score-matched study.
Yao J; Liu B; Wang X; Yu J; Cheng Z; Han Z; Liu F; Zheng R; Cheng W; Wei Q; Yu S; Li K; Chen P; Luo Y; Yu X; Liang P
Int J Hyperthermia; 2022; 39(1):209-216. PubMed ID: 35067144
[TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
[TBL] [Abstract][Full Text] [Related]
5. Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score-matched study of long-term therapeutic outcomes.
Liu K; Zheng H; Sui X; Liu B; Meng M; Feng Y; Zhu Q; Zhao X
Eur Radiol; 2023 Mar; 33(3):1938-1948. PubMed ID: 36114849
[TBL] [Abstract][Full Text] [Related]
6. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
Chen S; Shi M; Shen L; Qi H; Wan W; Cao F; Xie L; Wu Y; Chen G; Mo J; Zhu G; Ye D; Zhang Y; Feng Z; Xu L; Fan W
Int J Hyperthermia; 2020; 37(1):384-391. PubMed ID: 32323585
[No Abstract] [Full Text] [Related]
7. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
[TBL] [Abstract][Full Text] [Related]
8. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis.
Feng Y; Wang L; Lv H; Shi T; Xu C; Zheng H; Qi J; Zhao X; Li J; Gao Y; Qin C; Zhu Q
HPB (Oxford); 2021 Apr; 23(4):512-519. PubMed ID: 32839089
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Medium-Term Efficacy of Y90 Radiation Segmentectomy vs Percutaneous Microwave Ablation in Patients with Solitary Surgically Unresectable < 4 cm Hepatocellular Carcinoma: A Propensity Score Matched Study.
Arndt L; Villalobos A; Wagstaff W; Cheng B; Xing M; Ermentrout RM; Bercu Z; Cristescu M; Shah A; Wedd J; Majdalany BS; Magliocca JF; Sellers MT; Kokabi N
Cardiovasc Intervent Radiol; 2021 Mar; 44(3):401-413. PubMed ID: 33230652
[TBL] [Abstract][Full Text] [Related]
10. Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3-5-cm HCC.
Wang Z; Liu M; Zhang DZ; Wu SS; Hong ZX; He GB; Yang H; Xiang BD; Li X; Jiang TA; Li K; Tang Z; Huang F; Lu M; Chen JA; Lin YC; Lu X; Wu YQ; Zhang XW; Zhang YF; Cheng C; Ye HL; Wang LT; Zhong HG; Zhong JH; Wang L; Chen M; Liang FF; Chen Y; Xu YS; Yu XL; Cheng ZG; Liu FY; Han ZY; Tang WZ; Yu J; Liang P
Hepatology; 2022 Jul; 76(1):66-77. PubMed ID: 35007334
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a propensity score matching analysis.
Jin T; Liu X; Zhang H; Cao Y; Dai C; Tang S; Xu F
Int J Hyperthermia; 2020; 37(1):955-964. PubMed ID: 32781862
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
Shuanggang C; Shen L; Qiu Z; Qi H; Cao F; Xie L; Fan W
J Cancer Res Ther; 2020; 16(2):250-257. PubMed ID: 32474509
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography-guided percutaneous cryoablation and microwave ablation in the treatment of perivascular hepatocellular carcinoma: A comparative study with propensity score matching.
Li B; Ren ZW; Zhang C; Yu XX; Xu XX; Du Y; Yang HF
Clin Res Hepatol Gastroenterol; 2024 Mar; 48(3):102298. PubMed ID: 38367802
[TBL] [Abstract][Full Text] [Related]
14. Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness.
Huang T; Qi H; Shen L; Wu Y; Song Z; Cao F; Liu Y; Xie L; Chen S; Tang T; Li H; Zhang Y; Feng L; Zhang H; Chen J; Fan W
Int J Hyperthermia; 2022; 39(1):935-945. PubMed ID: 35853727
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival analysis of ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma conforming to the Milan criteria: primary versus recurrent HCC.
Zhang J; Guo G; Li T; Guo C; Han Y; Zhou X
Int J Hyperthermia; 2024; 41(1):2318829. PubMed ID: 38467417
[TBL] [Abstract][Full Text] [Related]
16. CT-guided
Chen Z; Fu X; Qiu Z; Mu M; Jiang W; Wang G; Zhong Z; Qi H; Gao F
Radiol Oncol; 2023 Mar; 57(1):127-139. PubMed ID: 36942903
[TBL] [Abstract][Full Text] [Related]
17. A multicenter case-controlled study on laparoscopic hepatectomy versus microwave ablation as first-line therapy for 3-5 cm hepatocellular carcinoma in patients aged 60 and older.
Wang Z; Zhang H; Meng Q; Zhang DZ; Wu SS; Hong ZX; He GB; Yang H; Xiang BD; Li X; Jiang TA; Li K; Tang Z; Huang F; Lu M; Liu C; Yu XL; Cheng ZG; Liu FY; Han ZY; Dou JP; Yu J; Liang P
Int J Surg; 2024 Mar; 110(3):1356-1366. PubMed ID: 38320101
[TBL] [Abstract][Full Text] [Related]
18. Single medium-sized hepatocellular carcinoma treated with sequential conventional transarterial chemoembolization (cTACE) and microwave ablation at 4 weeks versus cTACE alone: a propensity score.
Zhu ZY; Yuan M; Yang PP; Xie B; Wei JZ; Qin ZQ; Qian Z; Wang ZY; Fan LF; Qian JY; Tan YL
World J Surg Oncol; 2022 Jun; 20(1):192. PubMed ID: 35689233
[TBL] [Abstract][Full Text] [Related]
19. Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score-matched study of postoperative liver decompensation.
Yu H; Zhao F; Men X; Zhu H; Yan J; Liu Z; Liu Q; Feng Y; Wang L; Meng M; Zhu Q; Zhao X
Eur Radiol; 2024 May; 34(5):3226-3235. PubMed ID: 37875593
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis.
Suwa K; Seki T; Aoi K; Yamashina M; Murata M; Yamashiki N; Nishio A; Shimatani M; Naganuma M
Abdom Radiol (NY); 2021 Aug; 46(8):3790-3797. PubMed ID: 33675382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]